Skip to main content

Table 1 Overview on clinical reports

From: Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation

Authors

N° of cases

Treatment Options

Outcome

1. Radical surgery reports

Baker et al and Arnheim [25,26]

4

Orchiectomy/TURP/RP

Survival times: 1 to 3 mo.

Thompson et al [10]

7

TURP/Orchiectomy/ES

Survival times: 3 mo.-6 yrs range

   

5/7 pts survived less than 1 year

Sieracki [8]

3

RP/RT/ES

Survival times: 8 days-9 yrs range

Gray et al [18]

1

RP/Miles

Died 1 year after diagnosis

Corder et al [23]

1

TURP/RP/RT/Adriamycin

5 mo. response to CT

Samsonov [31]

3

RP

NA

Al Adnani [32]

2

RP

Not reported

Asuero et al [33]

1

RP

Alive 1 year after treatment

Sarma et al [35]

1

RCP/TP/SC/PS/Miles

Died 6 mo. after diagnosis of d-MTS

Masuda et al [19]

1

RP

Disease-free 6 yrs after surgery

Moskovitz et al [6]

1

RP

Died 5 mo. after diagnosis

Little et al [17]

2

RCP/PLND/TURP

Disease-free 40 mo. after surgery

  

RCP/PLND

Lung MTS 25 mo. after diagnosis

Braslis et al [15]

1

RCP

Disease-free 6 mo. after surgery

Okamoto et al [7]

1

RP/PLND/MPD

Died 14 mo. after surgery

Imamura et al [22]

1

RCP/MPD

Disease-free 5 yrs after surgery

Kanthan et al [45]

6

RP/RT/CT

Survival rates from 1 to 13 mo.

2. Radio-chemotherapy combined modality treatment reports

Inaba et al [49]

1

TURP/CDDP/RT

Died 13 months after diagnosis

Kuwahara et al [36]

1

TURP/CDDP/PEP/RT

Died 9 mo. after diagnosis

Uchibayashi et al [20]

1

TURP/Local RT/CDDP/BLM

Disease-free 21 mo. after diagnosis

Okada et al [21]

1

Local RT/CDDP/PEP

Disease-free 18 mo. after diagnosis

Present case

1

RT/CDDP/5-FU

5 yrs disease-free survival

3. Miscellaneous

Ray et al [27]

1

RT

Not reported

Kastendieck et al [28]

1

TURP/Orchiectomy/ES

Died 2 months after diagnosis

Mott [4]

2

TURP/RT

Died 8 mo. after diagnosis

  

Orchiectomy/RT/DES

Died 5 months after diagnosis

Sharma et al [29]

1

Orchiectomy

Died during diagnostic procedures

Miller et al [16]

1

CDDP/5-FU/Tax

SD for 6 months

Perez Garcia et al [37]

1

RT

Alive 5 mo. after treatment

Nabi et al [41]

2

TURP/Adriamycin

Died 5 mo. after diagnosis

Goto et al [42]

1

MTX/Pirarubicin/CDDP/TPE

Disease-free 12 mo. after therapy

Mayayo et al [44]

1

Local RT

Died 7 mo. after diagnosis

John et al [47]

1

TURP/RT

Died 24 mo. after diagnosis

Di Pietro et al [48]

1

TURP

Died during diagnostic work-up

4. Anecdotal reports

Spagnol [24]

1

None

Died 2 days after diagnosis

Kahaler [9]

6

Not reported

Not reported

Okamura et al [30]

1

NA

NA

Wernert et al [34]

1

Not reported

Not reported

Ulloa et al [38]

1

NA

NA

Rahmanou et al [39]

1

Not reported

Not reported

Puyol et al [40]

1

None

Local PD 6 mo. after diagnosis

Herrera et al [43]

1

None

Died 2 mo. after diagnosis

Mohan et al [5]

1

None

Discontinued follow-up

Parwani et al [46]

8

Not reported

Survival times: 5–48 mo.

  1. Only pure squamous cell carcinoma of the prostate gland have been included. TURP: transurethral resection of prostate; RP: radical prostatectomy; RT: radiotherapy; CT: chemotherapy; NA: not available (mainly due to articles written in languages others than English); ES: estrogen; DES: diethylstilbesterol; mo.: months; yrs: years; RCP: radical cystoprostatectomy; TP: total penectomy; SC: scrotectomy; PS: pubic symphysectomy; Miles: abdominoperineal resection of the rectum; d-MTS: distant metastases; CDDP: cisplatin; PEP: peplomycin; PLND: pelvic lymphadenectomy; 5-FU: 5-fluorouracil; Tax: paclitaxel; MPD: methotrexate-peplomycin-cisplatin; BLM: bleomycin; MTX: methotrexate; TPE: total pelvic exenteration.